
Purpose This study aims to examine how innovative work behavior (IWB) influences hospital performance (HP), with professional characteristics (ProC) and patient characteristics (PtC) as mediating factors. Furthermore, it examines whether the adoption of artificial intelligence (AI) moderates this relationship. Design/methodology/approach A structured questionnaire was used to collect data from 351 healthcare professionals in Pakistan. Partial least squares structural equation modeling was applied to test the hypotheses. Findings The results reveal that IWB has a significant, positive effect on HP, both directly and indirectly through ProC and PtC. These characteristics act as important underlying mechanisms through which IWB enhances performance outcomes. While AI adoption does not directly improve HP, it positively moderates the IWB–HP relationship, indicating that AI strengthens the performance outcomes of innovation-supportive environments. Originality/value This study integrates the resource-based view and job demands–resources into a nomological framework. It contributes to healthcare innovation research by showing that technological adoption alone is insufficient; employee innovative behavior and human-related characteristics are crucial drivers of HP.
The necessity for a work–life balance between family and career is growing along with the trend of working for employees, particularly health workers. This paper aims to examine emotional dynamics and work–life conflict in healthcare centres from emerging countries with reference to the Upper West Regional Hospital of Ghana. With a pragmatic perspective, the researchers reasoned that there are various ways to understand reality. In this study, an exploratory research design was adopted to examine the intricate connection between work–life conflict and employee frustration, job stress and job satisfaction at Upper West Regional Hospital. The authors used an exploratory design. The various respondents were chosen using a simple random technique. This study found that employees’ frustration is correlated with work–life conflicts. Additionally, job stress is correlated with work–life conflicts. Third, job satisfaction is correlated with work–life conflict. The findings underscore the complexity of the factors affecting work–life conflicts, employee well-being, job satisfaction and performance within the hospital. The findings imply that management of the hospital should devise strategies to support employees in managing their personal and professional lives to reduce frustration, lower job stress, increase job satisfaction and ultimately, improve performance. This research adopts the role theory to expand knowledge, and it is a foundation for understanding the intricate dimensions of emotional dynamics and work–life conflict in a healthcare setting in a unique West African emerging economy.
Purpose The growing use of digital platforms by pharmaceutical firms has fundamentally reshaped how consumers engage with over-the-counter (OTC) medicine information. This study aims to investigate how consumer perceptions of digital pharmaceutical marketing – specifically perceived informativeness, credibility and intrusiveness – shape OTC medicine purchase intention and self-reported purchase behaviour within an emerging market context. Design/methodology/approach Primary data were gathered through a structured survey of 412 consumers residing in Kolkata who had demonstrable prior exposure to digital pharmaceutical marketing. Established measurement scales were used to operationalise key perceptual constructs. A two-stage analytical framework was adopted: the first stage tested perceived informativeness, credibility and intrusiveness as antecedents of purchase intention (including moderation analysis); the second stage examined the pathways through which purchase intention and credibility jointly determine purchase behaviour. Findings Perceived informativeness and credibility each exert a significant positive influence on purchase intention, while perceived intrusiveness diminishes it. Purchase intention subsequently predicts purchase behaviour and credibility demonstrates an additional direct effect on behaviour beyond this intentional pathway – confirming a dual-path trust mechanism. Moderation analysis reveals that intrusiveness does not significantly condition the effects of either informativeness or credibility on intention; instead, it functions as an independent structural deterrent. Research limitations/implications The study is subject to certain limitations. It adopts a cross-sectional design, which restricts causal interpretation of the observed relationships. Purchase behaviour was measured using self-reported responses, which may be influenced by recall bias. In addition, the research focuses on consumers from a single metropolitan city, which may limit generalisability to rural or semi-urban contexts. Future research could use longitudinal or experimental designs, explore diverse geographic settings and examine emerging digital formats such as influencer-based health communication. Practical implications The findings underscore the primacy of credibility-driven communication in digital pharmaceutical marketing. Firms should prioritise transparency, evidence-based messaging and minimal intrusiveness to sustain consumer trust and convert digital engagement into actual purchase decisions. Segment-specific strategies – particularly for younger, digitally active consumers – are recommended. Social implications Digital pharmaceutical marketing increasingly shapes how consumers make self-medication decisions. The findings highlight the social importance of responsible and transparent digital communication in the pharmaceutical sector, particularly for OTC medicines where professional guidance may be limited. Emphasising credibility and avoiding intrusive promotional practices can help protect consumer trust and support informed health-related decision-making. The study underscores the need for ethical standards in digital pharmaceutical marketing to safeguard consumer well-being while promoting access to reliable medicine-related information. Originality/value This study advances the digital pharmaceutical marketing literature by proposing and empirically validating a two-stage information–trust–behaviour framework applicable to OTC medicine contexts in emerging markets. By isolating the direct behavioural role of credibility from its intentional pathway, the study offers a theoretically refined account of how trust operates in health-related digital decision-making environments characterised by information asymmetry and limited professional mediation.
Purpose This study aims to examine how framing in corporate social responsibility (CSR) communication influences corporate image and consumers’ trial intention in highly regulated pharmaceutical markets and whether corporate image mediates this relationship. Design/methodology/approach The investigation applies an explanatory quantitative design via a cross-sectional survey of 358 Indonesian respondents and analyses the data using partial least squares structural equation modelling with second-order constructs. Findings CSR communication significantly predicts corporate image and trial intention. Corporate image strongly predicts trial intention and partially mediates the CSR–intention link. The model explains 73% of the variance in corporate image and 57.3% in trial intention. Research limitations/implications Cross-sectional design and purposive sampling limit generalisability; longitudinal or experimental studies are recommended. Practical implications Pharmaceutical firms should craft credible, consistent and transparent CSR messages framed around social value to strengthen corporate image and stimulate trial behaviours within regulatory constraints. Originality/value This study extends CSR communication research by introducing trial intention as an early-stage behavioural outcome in highly regulated pharmaceutical markets. It also applies framing theory to explain how CSR narratives shape consumer responses. An important gap is addressed, as prior work has largely concentrated on purchase intention in less restrictive sectors. The findings offer a transferable model for compliance-driven industries, providing both theoretical advancement and actionable guidance for strategic CSR communication.
Purpose This study aims to focus on understanding the utilisation of artificial intelligence (AI)-enabled capabilities in e-pharmacies in India. The research is based on the principle of the technology acceptance model (TAM), and it is extended by introducing the notion of trust and decision-making, in addition to analysing the moderating effect of trust. Design/methodology/approach The questionnaire was structured, and the consumers surveyed in India had recently bought medicines using e-pharmacy sites in the past two months. Partial least squares structural equation modelling was then used to test hypothesised relationships, evaluate the measurement model and test moderation effects using only 384 valid responses. Findings The findings show a significant positive effect of perceived ease of use on perceived usefulness (PU) and consumer trust. Consumer decision-making (CDM) is significantly enhanced by PU and trust, and in turn exerts a strong influence on purchase intention (PI). In addition, consumer trust moderates the relationship between CDM and PI, such that the positive effect of decision-making on PI is significantly stronger at higher levels of consumer trust. The structural model demonstrates strong explanatory power and satisfactory predictive relevance. Practical implications The results indicate that providers of e-pharmacy should put more emphasis on intuitive design of AI, transparency and trust-building systems to enhance CDM and PI. Originality/value The paper makes contributions to the existing body of knowledge as it empirically confirms an extended TAM in the case of AI-based e-pharmacies and emphasises the essential moderating role of trust in digital commerce of healthcare-related products.